Key developments in pancreatic cancer from ESMO 2019

Prof Eileen O'Reilly and Dr Ian Chau
Key developments in pancreatic cancer from ESMO 2019 ( Prof Eileen O'Reilly and Dr Ian Chau )
2 Oct 2019

Radiotherapy for liver cancer, and neoadjuvant therapy for rectal cancer

Dr Parag Parikh - Mayo Clinic, Rochester, USA
Radiotherapy for liver cancer, and neoadjuvant therapy for rectal cancer ( Dr Parag Parikh - Mayo Clinic, Rochester, USA )
17 Jul 2019

Applied precision cancer medicine in advanced biliary tract cancer

Dr Hossein Taghizadeh - Medical University of Vienna, Vienna, Austria
Applied precision cancer medicine in advanced biliary tract cancer ( Dr Hossein Taghizadeh -  Medical University of Vienna, Vienna, Austria )
15 Jul 2019

Treating HER2-mutant advanced biliary tract cancer with neratinib

Dr James Harding - Memorial Sloan kettering Cancer Center, New York, USA
Treating HER2-mutant advanced biliary tract cancer with neratinib ( Dr James Harding - Memorial Sloan kettering Cancer Center, New York, USA )
15 Jul 2019

Latest advances in pancreatic cancer treatment and impact on practice

Prof Eric Van Cutsem and Dr Talia Golan
Latest advances in pancreatic cancer treatment and impact on practice ( Prof Eric Van Cutsem and Dr Talia Golan )
10 Jul 2019

Implementing national cancer control plans

Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019

Comment: POLO III trial for metastatic pancreatic cancer

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Comment: POLO III trial for metastatic pancreatic cancer ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
24 Jun 2019

Comment: Laparoscopic versus open resection for colorectal liver metastases

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Comment: Laparoscopic versus open resection for colorectal liver metastases ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
13 Jun 2019

ABC-06 results: Second-line ASC mFOLFOX chemotherapy for biliary tract cancer

Dr Angela Lamarca - The Christie NHS Foundation Trust, Manchester, UK
ABC-06 results: Second-line ASC mFOLFOX chemotherapy for biliary tract cancer ( Dr Angela Lamarca - The Christie NHS Foundation Trust, Manchester, UK )
11 Jun 2019

Managing metastatic breast cancer and beyond using PARP inhibitors

Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA
Managing metastatic breast cancer and beyond using PARP inhibitors ( Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA )
11 Jun 2019

POLO Trial: Olaparib as a maintenance treatment following first-line chemotherapy in patients with metastatic pancreatic cancer

Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona, Spain
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherapy in patients with metastatic pancreatic cancer ( Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona, Spain )
6 Jun 2019

Highlights from ASCO 2019

Asst. Prof Bishal Gyawali and Monique Biryiana
Highlights from ASCO 2019 ( Asst. Prof Bishal Gyawali and Monique Biryiana )
3 Jun 2019